JP2025063057A5 - - Google Patents

Download PDF

Info

Publication number
JP2025063057A5
JP2025063057A5 JP2024226066A JP2024226066A JP2025063057A5 JP 2025063057 A5 JP2025063057 A5 JP 2025063057A5 JP 2024226066 A JP2024226066 A JP 2024226066A JP 2024226066 A JP2024226066 A JP 2024226066A JP 2025063057 A5 JP2025063057 A5 JP 2025063057A5
Authority
JP
Japan
Prior art keywords
sequence
composition
polynucleotide
homology
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024226066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025063057A (ja
JP7851563B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/031009 external-priority patent/WO2018204734A1/en
Application filed filed Critical
Publication of JP2025063057A publication Critical patent/JP2025063057A/ja
Publication of JP2025063057A5 publication Critical patent/JP2025063057A5/ja
Application granted granted Critical
Publication of JP7851563B2 publication Critical patent/JP7851563B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024226066A 2017-05-05 2024-12-23 オトフェルリンを発現させるための組成物および方法 Active JP7851563B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762502462P 2017-05-05 2017-05-05
US62/502,462 2017-05-05
PCT/US2018/031009 WO2018204734A1 (en) 2017-05-05 2018-05-04 Compositions and methods for expressing otoferlin
JP2019560646A JP7240675B2 (ja) 2017-05-05 2018-05-04 オトフェルリンを発現させるための組成物および方法
JP2023027073A JP7617600B2 (ja) 2017-05-05 2023-02-24 オトフェルリンを発現させるための組成物および方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023027073A Division JP7617600B2 (ja) 2017-05-05 2023-02-24 オトフェルリンを発現させるための組成物および方法

Publications (3)

Publication Number Publication Date
JP2025063057A JP2025063057A (ja) 2025-04-15
JP2025063057A5 true JP2025063057A5 (https=) 2025-05-13
JP7851563B2 JP7851563B2 (ja) 2026-04-27

Family

ID=

Similar Documents

Publication Publication Date Title
JP2023070682A5 (https=)
CN105026554B (zh) 用于治疗mps1的组合物和方法
JP7654562B2 (ja) 線維芽細胞増殖因子２３関連低リン血症性疾患の遺伝子療法
JP2018513678A (ja) Ｆｖｉｉｉおよびｆｉｘ用の最適化された肝臓特異的発現系
CN110325199A (zh) 用于治疗苯丙酮尿症的基因疗法
JP2020518268A5 (https=)
JP2022000017A (ja) 補体媒介性疾患を処置するための組成物及び方法
CN111218446B (zh) 一种肝脏特异性启动子及其应用
RU2018143411A (ru) Лечение комплемент-опосредуемых расстройств
WO2020084161A1 (en) New tools for improving gene therapy and use thereof
JP2021533801A5 (https=)
JPWO2021102107A5 (https=)
JP2025063057A5 (https=)
JP7745307B2 (ja) 連結ペプチド、連結ペプチドを含む血液凝固ｖｉｉｉ因子タンパク質又はその変異体及びその用途
CN107073078A (zh) 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物
KR20260003703A (ko) 보체 장애의 치료를 위한 aav 변이체
WO2024138833A1 (zh) 一种改造的重组凝血因子viii及其应用
CN112041437A (zh) 用于恢复f8基因功能的腺相关病毒组合物和其使用方法
JP2024528997A (ja) 放射線誘発性唾液機能低下を予防するためのａｑｐ１遺伝子療法
CN116917471A (zh) 溶酶体酸性脂肪酶变体及其用途
JPWO2020038473A5 (https=)
JPWO2023036966A5 (https=)
JP2022506174A (ja) 改変第ｉｘ因子ポリペプチド
JPWO2021058830A5 (https=)
JPWO2022023761A5 (https=)